68Ga-HTK03149

DRUG2 trials

Sponsors

British Columbia Cancer Agency

Conditions

Castrate Resistant Prostate CancerMetastatic Castration-resistant Prostate CancerProstate Cancer MetastaticProstatic Cancer

Phase 1

177Lu-HTK03170 in mCRPC With PSMA Positive Disease

Enrolling by invitationNCT05570994

British Columbia Cancer AgencyCastrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic

Start: 2024-01-01End: 2027-05-01Target: 50Updated: 2026-01-08

Unknown Phase

Dynamic Whole Body PET/ MRI

WithdrawnNCT04495959

British Columbia Cancer AgencyProstatic Cancer

Start: 2025-08-01End: 2028-09-30Updated: 2025-01-08